
SPEAKERS
We invited speakers from various backgrounds and careers.
Learn more about them on this page.

Madina Simbargov
Financial Planning Consultant at Horbach
Madina Simbargov studied Business Mathematics at the University of Mannheim, graduating in 2023, and volunteered as a German-language teacher for women from diverse backgrounds. Since 2023, she has worked as an independent Financial Planning Consultant at HORBACH Rhein-Neckar, focusing on supporting expats through the German financial and retirement system with tailored insurance, investment, and wealth-management strategies.

Dr. Julieta Alfonso
Senior Editor at Nature Cancer
Julieta Alfonso completed her PhD in Molecular Biology and Biotechnology in Argentina before a postdoc in Prof. Hannah Monyer's lab at University Hospital Heidelberg. In 2014, she established her own group at the DKFZ's Department of Clinical Neurobiology, studying neural cell proliferation, brain vascular-nervous interactions, and glioblastoma lipid metabolism. She joined Nature Cancer as Senior Editor in 2024.

Dr. Loan Vulliard
AIH Postdoctoral Fellow at DKFZ
Loan Vulliard studied bioinformatics at INSA Lyon, with a semester at KAIST and cancer immunoinformatics internships in Montpellier and Copenhagen. He completed his PhD at CeMM Vienna in 2023 under Prof. Menche, then joined Heidelberg as an AI Health Innovation Cluster postdoctoral fellow with Dr. Hartmann and Prof. Saez-Rodriguez, developing computational methods to profile the tumor immune microenvironment from multiplexed imaging data.

Dr. Kevin Jahnke
Group Leader at the Heilbronn Max Planck Institute for Medical Research
Kevin Jahnke studied physics in Heidelberg, completed his master at the University of Cambridge and then joined the Max Planck Institute for Medical Research for his PhD. He worked as a postdoctoral fellow at Harvard University and now heads his own group at the Max Planck Institute. His work focuses on engineering synthetic lipid nano- and microstructures, with the aim of investigating the biophysics of both cells and lipid vesicles.

Prof. Dr. Tsing-Young Dora Tang
Professor for Synthetic Biology, University of Saarland
Dora Tang completed her PhD in membrane biophysics at Imperial College London, followed by postdoctoral work at the University of Bristol and the BrisSynBio consortium. She led an independent group at the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden before becoming Professor for Synthetic Biology at Saarland University in 2023. Her research uses bottom-up synthetic biology and biophysics to build minimal semi-synthetic cells. She holds an ERC Consolidator Grant and was named a "Cell Scientist to Watch."

Dr. Simone Seiter
Head of Commercial Strategy Pharma & Biotech at Simon-Kucher
Simone Seiter trained as a physician, working as a dermatologist in Heidelberg and Homburg and as a postdoctoral fellow at the NCI/NIH, before moving into consulting at Capgemini and then IQVIA, where she spent 13 years in brand and commercial strategy. She has been an independent director of a listed ophthalmology gene therapy company since 2017, and is now Senior Partner and Head of Commercial Strategy Pharma & Biotech at Simon-Kucher.

Dr. Daniel Hürtgen
Patent Attorney at Boehringer Ingelheim
Daniel Hürtgen studied molecular biotechnology at Bielefeld University, MIT, and Cambridge, then completed his PhD and a postdoctoral year at the Max Planck Institute for Terrestrial Microbiology in Marburg, working on bottom-up synthetic biology and minimal-cell segregation machineries. He then trained as a patent attorney in Düsseldorf, at the DPMA, and the Federal Patent Court, and has worked as a patent attorney for Boehringer Ingelheim since 2024.

Dr. Manuel Rodriguez Paredes
Deputy Head of the Epigenetics Division at DKFZ
Manuel Rodriguez Paredes earned his PhD at CABIMER after studying Biological Sciences in Seville. Following a postdoc in Barcelona, he joined the DKFZ in Heidelberg in 2014, using skin models and single-cell sequencing to study aging and cancer, and developed the first epidermis-specific epigenetic clock. After leading his own group at the University of Mainz, he returned to the DKFZ as deputy head of the Epigenetics Division.

Victoria Summers
Communications Officer at UAR
Victoria Summers joined Understanding Animal Research (UAR) in 2025 after research roles in the UK and Japan. At the UK Health Security Agency, she led in-vivo projects including SARS-CoV-2 therapeutic efficacy studies, and previously conducted cancer immunotherapy research at Yamaguchi University, Japan. At UAR, she manages social media and digital content on animal research in science and medicine.

Dr. Ken Sachenbacher
Postdoc and DNA/RNA origami facility lead at ZMBH
Ken Sachenbacher completed his master’s and PhD in Biophysics at the Technical University of Munich. During his PhD he worked on building pH-responsive reversible DNA origami structures. He joined the Göpfrich group at the ZMBH in Heidelberg as a postdoctoral fellow in 2025, where he translates his work on DNA origami to RNA structures and additionally leads the DNA origami facility.
